Docket Management
Docket: 03N-0059 - Pharmaceutical Current Good Manufacturing Practices for the 21st Century: A Risk-Based Approach
Comment Number: EC -10

Accepted - Volume 1

Comment Record
Commentor Mr. kenneth bean Date/Time 2003-03-07 09:01:06
Organization na
Category Individual

Comments for FDA General
1. General Comments I think that 21 CFR Part 11 should at the very least should remain in effect, if no become more restrictive. There are just to many reason why the FDA should protect the general public health and 21 CFR Part 11 helps to ensure this critical issues!

EC -10